View of First-line treatment of metastatic HER2-positive breast cancer with dual anti-HER2 therapy and docetaxel: a case report

Return to Article Details First-line treatment of metastatic HER2-positive breast cancer with dual anti-HER2 therapy and docetaxel: a case report Download Download PDF